Akzo Nobel: Strong Operational Focus in Transformational Year

Amsterdam, the Netherlands, March 6, 2008 – Akzo Nobel (Euronext Amsterdam: AKZ) has reported 5% autonomous growth and a 29% rise in net income before incidentals for 2007. In what was a transformational year, the company was able to maintain a strong operational focus.

Highlights for the year

• 5% autonomous growth
• EBIT up 25%; reaping the benefits of margin management and cost savings
• EBITDA margin further improved to 12.4%
• Pension deficit significantly down from EUR 1.8 billion to EUR 1.1 billion
• EUR 8.5 billion profit on the divestment of Organon BioSciences
• Start of additional EUR 3 billion share buyback program announced
• Dividend increased 50% from EUR 1.20 to EUR 1.80 per common share
• Incidentals – EUR 169 million loss compared with 2006 gain of EUR 126 million